A citation-based method for searching scientific literature

Wenhao Zhang, Dik C van Gent, Luca Incrocci, Wytske M van Weerden, Julie Nonnekens. Prostate Cancer Prostatic Dis 2020
Times Cited: 12







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
41



BRCA2 and Other DDR Genes in Prostate Cancer.
Paz Nombela, Rebeca Lozano, Alvaro Aytes, Joaquin Mateo, David Olmos, Elena Castro. Cancers (Basel) 2019
47
25

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
25

Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.
Likun Li, Styliani Karanika, Guang Yang, Jiangxiang Wang, Sanghee Park, Bradley M Broom, Ganiraju C Manyam, Wenhui Wu, Yong Luo, Spyridon Basourakos,[...]. Sci Signal 2017
114
25

Androgen receptor signaling regulates DNA repair in prostate cancers.
William R Polkinghorn, Joel S Parker, Man X Lee, Elizabeth M Kass, Daniel E Spratt, Phillip J Iaquinta, Vivek K Arora, Wei-Feng Yen, Ling Cai, Deyou Zheng,[...]. Cancer Discov 2013
291
25

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
25

DNA Repair in Prostate Cancer: Biology and Clinical Implications.
Joaquin Mateo, Gunther Boysen, Christopher E Barbieri, Helen E Bryant, Elena Castro, Pete S Nelson, David Olmos, Colin C Pritchard, Mark A Rubin, Johann S de Bono. Eur Urol 2017
133
25

Prostate cancer and PARP inhibitors: progress and challenges.
Diego Teyssonneau, Henri Margot, Mathilde Cabart, Mylène Anonnay, Paul Sargos, Nam-Son Vuong, Isabelle Soubeyran, Nicolas Sevenet, Guilhem Roubaud. J Hematol Oncol 2021
19
25

The Identification of Potent, Selective, and Orally Available Inhibitors of Ataxia Telangiectasia Mutated (ATM) Kinase: The Discovery of AZD0156 (8-{6-[3-(Dimethylamino)propoxy]pyridin-3-yl}-3-methyl-1-(tetrahydro-2 H-pyran-4-yl)-1,3-dihydro-2 H-imidazo[4,5- c]quinolin-2-one).
Kurt G Pike, Bernard Barlaam, Elaine Cadogan, Andrew Campbell, Yingxue Chen, Nicola Colclough, Nichola L Davies, Camila de-Almeida, Sebastien L Degorce, Myriam Didelot,[...]. J Med Chem 2018
52
16

ATM in DNA repair in cancer.
Mei Hua Jin, Do-Youn Oh. Pharmacol Ther 2019
73
16

The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.
Stephen T Durant, Li Zheng, Yingchun Wang, Kan Chen, Lingli Zhang, Tianwei Zhang, Zhenfan Yang, Lucy Riches, Antonio G Trinidad, Jacqueline H L Fok,[...]. Sci Adv 2018
107
16

Preclinical evaluation of a novel ATM inhibitor, KU59403, in vitro and in vivo in p53 functional and dysfunctional models of human cancer.
Michael A Batey, Yan Zhao, Suzanne Kyle, Caroline Richardson, Andrew Slade, Niall M B Martin, Alan Lau, David R Newell, Nicola J Curtin. Mol Cancer Ther 2013
96
16

Ataxia telangiectasia and Rad3-related inhibitors and cancer therapy: where we stand.
Lin Mei, Junran Zhang, Kai He, Jingsong Zhang. J Hematol Oncol 2019
57
16

Structural basis of homologous recombination.
Yueru Sun, Thomas J McCorvie, Luke A Yates, Xiaodong Zhang. Cell Mol Life Sci 2020
40
16

PARP Inhibitors in Prostate and Urothelial Cancers.
Rohan Garje, Raju Kumar Vaddepally, Yousef Zakharia. Front Oncol 2020
9
22

The DNA damage response: making it safe to play with knives.
Alberto Ciccia, Stephen J Elledge. Mol Cell 2010
16

Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.
Yi-Mi Wu, Marcin Cieślik, Robert J Lonigro, Pankaj Vats, Melissa A Reimers, Xuhong Cao, Yu Ning, Lisha Wang, Lakshmi P Kunju, Navonil de Sarkar,[...]. Cell 2018
272
16

The Cyclin K/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes.
Dalibor Blazek, Jiri Kohoutek, Koen Bartholomeeusen, Eric Johansen, Petra Hulinkova, Zeping Luo, Peter Cimermancic, Jernej Ule, B Matija Peterlin. Genes Dev 2011
284
16

Castration therapy results in decreased Ku70 levels in prostate cancer.
Firas L T Al-Ubaidi, Niklas Schultz, Olga Loseva, Lars Egevad, Torvald Granfors, Thomas Helleday. Clin Cancer Res 2013
49
16

Recent Advances in Prostate Cancer Treatment and Drug Discovery.
Ekaterina Nevedomskaya, Simon J Baumgart, Bernard Haendler. Int J Mol Sci 2018
110
16

Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling.
Styliani Karanika, Theodoros Karantanos, Likun Li, Jianxiang Wang, Sanghee Park, Guang Yang, Xuemei Zuo, Jian H Song, Sankar N Maity, Ganiraju C Manyam,[...]. Cell Rep 2017
49
16

Alpha emitter radium-223 and survival in metastatic prostate cancer.
C Parker, S Nilsson, D Heinrich, S I Helle, J M O'Sullivan, S D Fosså, A Chodacki, P Wiechno, J Logue, M Seke,[...]. N Engl J Med 2013
16

Coordination of DNA single strand break repair.
Rachel Abbotts, David M Wilson. Free Radic Biol Med 2017
105
16

DNA Damage Response in Prostate Cancer.
Matthew J Schiewer, Karen E Knudsen. Cold Spring Harb Perspect Med 2019
17
16

CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors.
Emmanuel S Antonarakis, Pedro Isaacsson Velho, Wei Fu, Hao Wang, Neeraj Agarwal, Victor Sacristan Santos, Benjamin L Maughan, Roberto Pili, Nabil Adra, Cora N Sternberg,[...]. JCO Precis Oncol 2020
76
16

Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation.
Simon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, Richard Newman, Dominik Mumberg, Bernard Haendler. Mol Oncol 2020
11
18

Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.
Lucy C Riches, Antonio G Trinidad, Gareth Hughes, Gemma N Jones, Adina M Hughes, Andrew G Thomason, Paul Gavine, Andy Cui, Stephanie Ling, Jonathan Stott,[...]. Mol Cancer Ther 2020
50
16

Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors.
Vibha Singh, Praveen Kumar Jaiswal, Ishita Ghosh, Hari K Koul, Xiuping Yu, Arrigo De Benedetti. Int J Cancer 2019
23
16

Dysregulated Transcriptional Control in Prostate Cancer.
Simon J Baumgart, Ekaterina Nevedomskaya, Bernard Haendler. Int J Mol Sci 2019
14
16

The DNA Damaging Revolution: PARP Inhibitors and Beyond.
Timothy A Yap, Ruth Plummer, Nilofer S Azad, Thomas Helleday. Am Soc Clin Oncol Educ Book 2019
91
16

Identification of Novel Biomarkers of Homologous Recombination Defect in DNA Repair to Predict Sensitivity of Prostate Cancer Cells to PARP-Inhibitors.
Daniela Criscuolo, Francesco Morra, Riccardo Giannella, Aniello Cerrato, Angela Celetti. Int J Mol Sci 2019
20
16

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
819
16

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
16

Epidemiology of Prostate Cancer.
Prashanth Rawla. World J Oncol 2019
618
16

Genomic rearrangements in prostate cancer.
Christopher E Barbieri, Mark A Rubin. Curr Opin Urol 2015
21
16



Targeted Next-Generation Sequencing in Men with Metastatic Prostate Cancer: a Pilot Study.
Pedro C Barata, Prateek Mendiratta, Brandie Heald, Stefan Klek, Petros Grivas, Davendra P S Sohal, Jorge A Garcia. Target Oncol 2018
9
22

Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Joaquin Mateo, Nuria Porta, Diletta Bianchini, Ursula McGovern, Tony Elliott, Robert Jones, Isabel Syndikus, Christy Ralph, Suneil Jain, Mohini Varughese,[...]. Lancet Oncol 2020
257
16

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
16

Genomics of lethal prostate cancer at diagnosis and castration resistance.
Joaquin Mateo, George Seed, Claudia Bertan, Pasquale Rescigno, David Dolling, Ines Figueiredo, Susana Miranda, Daniel Nava Rodrigues, Bora Gurel, Matthew Clarke,[...]. J Clin Invest 2020
97
16

AR-V7 and resistance to enzalutamide and abiraterone in prostate cancer.
Emmanuel S Antonarakis, Changxue Lu, Hao Wang, Brandon Luber, Mary Nakazawa, Jeffrey C Roeser, Yan Chen, Tabrez A Mohammad, Yidong Chen, Helen L Fedor,[...]. N Engl J Med 2014
16

A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
Eric A Klein, Matthew R Cooperberg, Cristina Magi-Galluzzi, Jeffry P Simko, Sara M Falzarano, Tara Maddala, June M Chan, Jianbo Li, Janet E Cowan, Athanasios C Tsiatis,[...]. Eur Urol 2014
405
16


Mechanisms of DNA damage, repair, and mutagenesis.
Nimrat Chatterjee, Graham C Walker. Environ Mol Mutagen 2017
497
16

Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY Study.
Andrew J Armstrong, Susan Halabi, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel C Danila, Patrick Healy, Monika Anand, Colin J Rothwell,[...]. J Clin Oncol 2019
178
16

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.
Hyuna Sung, Jacques Ferlay, Rebecca L Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray. CA Cancer J Clin 2021
16

Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.
David J Mulholland, Linh M Tran, Yunfeng Li, Houjian Cai, Ashkan Morim, Shunyou Wang, Seema Plaisier, Isla P Garraway, Jiaoti Huang, Thomas G Graeber,[...]. Cancer Cell 2011
369
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.